OVID THERAPEUTICS INC (OVID) Stock Earnings & Estimates
NASDAQ:OVID - US6904691010 - Common Stock
1.25 USD
-0.01 (-0.79%)
1.27 USD
+0.02 (+1.6%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.5M -99.28% | 391.7K -73.89% | 566K 44.50% | 4.574M 708.13% | 185.64K -95.94% | 229.5K 23.63% | 1.239M 439.87% | 15.866M 1,180.55% | 77.661M 389.48% | 347.93M 348.01% | 1.074B 208.68% | |
| EBITDA YoY % growth | -55M -144.21% | -57.685M -4.88% | -60.175M -4.32% | -58.65M 2.53% | -53.876M 8.14% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -55.5M -144.69% | -59.282M -6.81% | -61.885M -4.39% | -48.91M 20.97% | -54.337M -11.10% | -78.542M -44.55% | -97.251M -23.82% | -63.503M 34.70% | -1.054M 98.34% | 185.42M 17,692.09% | 661.26M 256.63% | |
| Operating Margin | -3,700.00% | -15,134.41% | -10,933.75% | -1,069.30% | -29,269.92% | -34,222.96% | -7,849.14% | -400.24% | -1.36% | 53.29% | 61.57% | |
| EPS YoY % growth | -0.77 -137.93% | -0.75 2.60% | -0.38 49.33% | -0.55 -43.56% | -0.61 -10.97% | -0.86 -41.53% | -0.94 -10.12% | -1.04 -10.27% | -0.87 16.67% | 0.56 164.71% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 26.22% | -0.14 -10.37% | -0.15 -9.58% | -0.15 -151.60% | -0.15 -1.75% | -0.16 -10.90% |
| Revenue Q2Q % growth | 181.05K 4.65% | 56.947K -25.07% | 112.2K -13.69% | 112.2K -98.21% | 125.797K -30.52% | 95.197K 67.17% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.612M 19.76% | -10.672M 0.47% | -12.05M 3.98% | -12.216M 1.10% | -12.384M -16.69% | -14.819M -38.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.06 -150.00% | -0.16 | 0.10 | 63.62% |
| Q1 2025 Q2Q % growth | -0.14 17.65% | -0.14 | 0.00 | -0.43% |
| Q4 2024 Q2Q % growth | -0.13 40.91% | -0.17 | 0.04 | 23.22% |
| Q3 2024 Q2Q % growth | -0.20 -25.00% | -0.21 | 0.01 | 3.83% |
| Q2 2024 Q2Q % growth | 0.12 166.67% | -0.23 | 0.35 | 152.99% |
| Q1 2024 Q2Q % growth | -0.17 10.53% | -0.22 | 0.05 | 23.51% |
| Q4 2023 Q2Q % growth | -0.22 -37.50% | -0.05 | -0.17 | -333.89% |
| Q3 2023 Q2Q % growth | -0.16 5.88% | -0.19 | 0.03 | 16.83% |
| Q2 2023 Q2Q % growth | -0.18 14.29% | -0.21 | 0.03 | 13.75% |
| Q1 2023 Q2Q % growth | -0.19 17.39% | -0.17 | -0.02 | -8.77% |
| Q4 2022 Q2Q % growth | -0.16 -60.00% | -0.19 | 0.03 | 13.93% |
| Q3 2022 Q2Q % growth | -0.17 | -0.22 | 0.05 | 22.21% |
| Q2 2022 Q2Q % growth | -0.21 8.70% | -0.25 | 0.04 | 17.23% |
| Q1 2022 Q2Q % growth | -0.23 -109.09% | -0.21 | -0.02 | -8.80% |
| Q4 2021 Q2Q % growth | -0.10 70.59% | -0.16 | 0.06 | 39.20% |
| Q3 2021 Q2Q % growth | -0.17 39.29% | -0.19 | 0.02 | 9.30% |
| Q2 2021 Q2Q % growth | -0.23 43.90% | -0.17 | -0.06 | -39.19% |
| Q1 2021 Q2Q % growth | 2.53 783.78% | 1.71 | 0.82 | 47.80% |
| Q4 2020 Q2Q % growth | -0.34 2.86% | -0.32 | -0.02 | -7.58% |
| Q3 2020 Q2Q % growth | -0.28 34.88% | -0.37 | 0.09 | 24.14% |
| Q2 2020 Q2Q % growth | -0.41 -20.59% | -0.36 | -0.05 | -12.77% |
| Q1 2020 Q2Q % growth | -0.37 19.57% | -0.34 | -0.03 | -9.38% |
| Q4 2019 Q2Q % growth | -0.35 | -0.42 | 0.07 | 16.10% |
| Q3 2019 Q2Q % growth | -0.43 | -0.37 | -0.06 | -15.93% |
| Q2 2019 Q2Q % growth | -0.34 | -0.44 | 0.10 | 22.84% |
| Q1 2019 Q2Q % growth | -0.46 | -0.43 | -0.03 | -6.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 6.272M 3,611.24% | 78.203K | 6.194M | 7,920.11% |
| Q1 2025 Q2Q % growth | 130K -12.16% | 51K | 79K | 154.90% |
| Q4 2024 Q2Q % growth | 76K -46.48% | 193.076K | -117.076K | -60.64% |
| Q3 2024 Q2Q % growth | 173K 58.76% | 88.883K | 84.117K | 94.64% |
| Q2 2024 Q2Q % growth | 169K 125.33% | 71.4K | 97.6K | 136.69% |
| Q1 2024 Q2Q % growth | 148K 123.70% | 60.761K | 87.239K | 143.58% |
| Q4 2023 Q2Q % growth | 142K | 57.63K | 84.37K | 146.40% |
| Q3 2023 Q2Q % growth | 108.97K | 51K | 57.97K | 113.67% |
| Q2 2023 Q2Q % growth | 75K | 48.705K | 26.295K | 53.99% |
| Q1 2023 Q2Q % growth | 66.16K -95.27% | 19.043K | 47.117K | 247.42% |
| Q1 2022 Q2Q % growth | 1.4M -99.33% | 1.4M | % | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 208.4M | 123.05M | 85.35M | 69.36% |
| Q4 2020 Q2Q % growth | 5.7M | 4.248M | 1.452M | 34.18% |
| Q3 2020 Q2Q % growth | 6.9M | 84.997K | 6.815M | 8,017.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.04% | 13.69% | 11.31% |
| Revenue | 0% | -4.16% | 1331.18% | 1753.02% |